Figure 8From: Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP) Genotoxin effects on CyclinA2 subets of leukemic cells or lymphocytes from myeloid growth factor stimulated AML samples. Shown are flow plot examples of CyclinA2 vs. p-H2AX for leukemic AML cells (left) or normal lympohcytes (right) gated (see Materials and methods) from 5 AML samples treated with etoposide (30 μg/mL), PARP inhibitor AZD2281 (6 μg/mL), temozolomide (10 μg/mL), or the combination of AZD2281 + temozolomide (6 μg/mL + 10 μg/mL) for 6 hr. While leukemic CyclinA2+ cells show induced p-H2AX from all agents tested, leukemic and lymphocytic CyclinA2- cells only demonstrate induced p-H2AX after etoposide treatment.Back to article page